QWQiang Wei

Qiang Wei

*This is an algorithmically generated author record based on publicly available information.

Qiang Wei has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Boxiong Cao

    First Peoples Hosp Shuangliu Dist, Dept Thorac Surg, 120 Chengbei Upper St, Chengdu, Peoples R China

    3 shared publications
  • Hao Feng

    First Peoples Hosp Shuangliu Dist, Dept Thorac Surg, 120 Chengbei Upper St, Chengdu, Peoples R China

    3 shared publications
  • Gaigai Huang

    First Peoples Hosp Shuangliu Dist, Dept Clin Lab, Chengdu, Peoples R China

    2 shared publications
  • Zemin He

    Department of Thoracic Surgery, The First People’s Hospital of Shuangliu District (West China Airport Hospital of Sichuan University), Chengdu, Sichuan, China

    2 shared publications
  • Ziliang Zan

    First Peoples Hosp Shuangliu Dist, Dept Thorac Surg, 120 Chengbei Upper St, Chengdu, Peoples R China

    2 shared publications
  • Hao Huang

    First Peoples Hosp Shuangliu Dist, Dept Thorac Surg, 120 Chengbei Upper St, Chengdu, Peoples R China

    1 shared publication

Latest Publications

  • Open Access

    Analysis of screen-detected pulmonary nodules before and after the novel coronavirus epidemic: a multicenter retrospective cohort study

    by Zemin He, Keting Liu, Ling Wu, Qiang Wei, Qingwei Shen

    Objective: To analyze the screening results for pulmonary nodules before and after the COVID-19 epidemic to understand the influence of the COVID-19 epidemic on the detection rate of pulmonary nodules and the detection rate of high-risk pulmonary nodules.Methods: A total of 18,906 chest CT scans were performed between March and November 2022 and between March and November 2023. Subjects from March to December 2022 were divided into the pre-epidemic group, and subjects from March to December 2023 were divided into the post-epidemic group. The detection rates of lung nodules, high risk nodules, different age groups, and gender groups were analyzed.Results: A total of 11513 lung nodules were detected during screening. A total of 841 high risk nodules were detected, and the detection rate of solid nodules was significantly higher in the postepidemic group than in the pre-epidemic group. The detection rate of fibrotic changes was significantly higher in the postepidemic group than in the pre-epidemic group. The detection rate of pulmonary nodules is significantly higher in those aged > 51 years compared to those aged 50 years and below.Conclusion: In the post-COVID-19 period, there has been a significant increase in the detection of solid pulmonary nodules. This increased detection rate is predominantly observed in medical patients over 51 years of age. However, the COVID-19 epidemic has not resulted in an increased detection rate of high risk nodules.


    • 1 November 2023
      • Vol. 53  (6) , 872-880

    Estradiol and Benzo[a]pyrene Co-Exposure Contributes to Lung Cancer Cell A549 Proliferation through AHR/AKT/ERK1/2 Pathway

    by Gaigai Huang, Hao Feng, Yu Zhou, Boxiong Cao, Ziliang Zan, Zemin He, Hao Huang, Xiaomin Luo, Qiang Wei

    Objective. Estrogen may have a certain role in promoting lung cancer caused by tobacco. Our understanding of the carcinogenic effects and mechanisms of carcinogen mixture estrogen is limited and mostly relies on the findings from studying individual factors. Methods. To test this hypothesis, an in-vitro study was used to investigate the effects of 17 (3-estradiol (E-2) on benzo[a]pyrene (Bap)-induced lung cancer cell A549 proliferation. Results. We first found that E-2 was increased in serum samples from lung adenocarcinoma cancer (LUAD) patients, even to a small extent. We found that Bap could enhance colony formation ability, up-regulate proliferating cell nuclear antigen (PCNA) and B-cell lymphoma-2 (Bcl-2) expression, induce cell proliferation and inhibit apoptosis in A549 cells. E-2 promoted these effects of Bap. Moreover, E2 and Bap co-exposure promoted lung cancer cell proliferation by activating the aryl hydrocarbon receptor (AHR)/protein kinase B (AKT)/extracellular regulated protein kinases (ERK1/2) signaling pathway. Inhibition of the AKT and ERK1/2 signaling pathways suppressed E-2 and Bap co-exposure's effect on A549 cells proliferation and apoptosis. Conclusions. Collectively, we conclude that E-2 could promote the proliferative and antiapoptotic effects of Bap on A549 cells, and activation of the AHR/AKT/ ERK1/2 pathway may be involved in this process.


  • Open Access

    Maximum amplitude and mean platelet volume in the blood as biomarkers to detect lung adenocarcinoma cancer featured with ground-glass nodules

    by Hao Feng, Gaigai Huang, Boxiong Cao, Ziliang Zan, Qiang Wei

    Objectives: The development and progression of malignancies are closely linked to hypercoagulability. As an early type of lung adenocarcinoma, ground glass nodules (GGNs) have been detected increasingly. Blood Maximum amplitude (MA) and mean platelet volume (MPV) are related to various conditions of hypercoagulability. Therefore, the role of MA and MPV in diagnosing lung adenocarcinoma cancer featured with GGNs was investigated in this case-control study. Methods: The analyzed data of this study is derived from GGNs patients and healthy individuals in West China (Airport) Hospital Sichuan University. The differences between GGNs patients and healthy individuals were determined by one-way ANOVA, logistic regression or chi-squared test. The accuracy of diagnostic was performed by receiver operating characteristic curve (ROC). The relative mRNA expressions were studied by RT-qPCR. Results: 470 patients diagnosed with GGNs which benign lesions (BN group) are inflammatory and malignant lesions (LC group) are adenocarcinoma in stage IA, and 235 healthy subjects (HC group) were enrolled in this study. Levels of MA and MPV were increased in LC group compared with BN and HC group ( p < 0.001, p < 0.001). When we combined MA and MPV, MA and MPV presented a sensitivity (SEN) of 0.809 and a specificity (SPE) of 0.774. And the area under the curve (AUC) increased to 0.871 (0.837–0.900) when confidence interval was 95%. Conclusion: This study demonstrates that there have been systemic changes in coagulation disorders in the pathogenesis of GGNs. The diagnostic ability to different lung adenocarcinoma cancer featured with GGNs from benign or healthy controls can be improved by the combination of MA and MPV. Maximum amplitude and MPV may be used as biomarkers to detect lung adenocarcinoma cancer featured with GGNs.

  • Open Access

    Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer

    by Hao Feng, Boxiong Cao, Xuan Peng, Qiang Wei

    The tumor microenvironment is a dynamic cellular milieu that interacts with cancer cells and promotes tumor progression and metastasis. However, the specific mechanisms by which the tumor microenvironment impacts cancer cells’ behaviors remain poorly understood. In this study, enriched cancer-associated fibroblasts (CAFs) were observed in tumor tissues isolated from epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) resistant non-small cell lung cancer (NSCLC) patients. CAFs isolated from tumor tissues were capable of producing tryptophan metabolite kynurenine (Kyn), which significantly increased the proliferation and EGFR TKIs resistance of NSCLC cells. In this study, it was further observed that the activation of tryptophan 2,3-dioxygenase (TDO) in CAFs, resulted in the enhanced capability of tryptophan metabolism in them compared to normal fibroblasts. As a result, Kyn produced by CAFs facilitated the up-regulation of Aryl Hydrocarbon Receptor (AhR) signals in NSCLC, thereby resulting in the downstream ATK and ERK signaling pathways activation. Finally, inhibition of AhR signals efficiently prevented tumor growth and development of EGFR TKIs resistance, eventually improved the outcome of EGFR TKIs, and described a promising therapeutic strategy for NSCLC.